Press Releases

YOKNEAM, Israel , Jan. 27, 2020 /PRNewswire/ -- Lumenis Ltd., the world's largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, announces the launch of its newest platform, the LightSheer Quattro. Following a successful US launch in 2019 the p

DALLAS, Jan. 27, 2020 /PRNewswire/ -- Veneto Holdings, LLC, is a private business; its shareholders are or were private shareholders of Generex Biotechnology, Inc. ("Generex").  Veneto writes to correct the false record Generex, and its CEO, Joe Moscato, have placed in the public domain. Mr. Moscato has made numerous false

MADISON, Wis., Jan. 27, 2020 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its fourth-quarter and full-year 2019 financial results after the close of the U.S. financial markets on Feb. 11, 2020. Following the release, company management will host a webcast and conference call at

SHENZHEN, China, Jan. 27, 2020 /PRNewswire/ -- ZTE Corporation (0763.HK/000063,SZ), a major international provider of telecommunications, enterprise and consumer technology solutions for the Mobile Internet, and Sichuan Branch of China Telecom today have realized China's first 5G remote diagnosis of n

LUND, Sweden, Jan. 27, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the patient enrollment in an investigator-initiated phase 2 study to evaluate safety, tolerability and efficacy of imlifidase in 15 patients with severe Anti-GBM antibody disease has now been completed. A

CAMBRIDGE, Mass., Jan. 27, 2020 /PRNewswire/ -- Quench Bio, a company leveraging new insights into gasdermin biology and innate immunology to develop medicines for severe inflammatory diseases, today announced the completion of a $50 million Series A financing led by RA Capital Management ("RA Capital"), with participation from new Inve

NORTH CHICAGO, Ill. and DUBLIN, Jan. 27, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, and Allergan (NYSE: AGN), a leading global pharmaceutical company, today announced that Allergan has entered into definitive agreements to divest brazikumab (IL-23 inhibitor) and Zenpep (pancrelipase).

MIAMI, Jan. 26, 2020 /PRNewswire/ -- GENYOUth, through their flagship Fuel Up to Play 60 program, and Sleep Number, the smart bed company, today announced the winners of their Super Sleep Contest. The organizations jointly challenged students nationwide to showcase the super things their schools can do when everyone gets quality sleep, for a chance to win a Sle

SAN FRANCISCO, Jan. 25, 2020 /PRNewswire/ -- Four babies who were introduced prenatally in 2019 made an appearance in their mothers' arms at this year's 16th Annual Walk for Life West Coast, as tens of thousands of pro-lifers rallied and then walked for nearly two miles across downtown San Francisco.

SHANGHAI, Jan. 25, 2020 /PRNewswire/ -- Further to the earlier statement on 23 January, Trip.com Group today announced that it would expand the "Cancellation Guarantee" initiative to include hotels outside of China.